Latent Tuberculosis Infection Detection Market Forecast Shows Steady Adoption in Hospitals and Clinical Laboratories

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Latent Tuberculosis Infection Detection Market is valued at US$ 1.53 Bn in 2023, and it is expected to reach US$ 2.37 Bn by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2579

Latent Tuberculosis Infection (LTBI) is characterized by the presence of Mycobacterium tuberculosis in individuals who do not exhibit clinical symptoms of active tuberculosis (TB). Accurate detection of LTBI is essential to prevent its progression to active disease. The LTBI diagnostics market is experiencing steady growth, driven by the increasing risk of active TB development and rising public awareness of the importance of early TB screening. Key contributing factors include the expanding elderly population, which exhibits higher TB susceptibility, and the growing focus on preventive healthcare and early intervention strategies.

Government-led initiatives aimed at raising TB awareness, along with advancements in diagnostic technologies, are expected to significantly bolster market expansion during the forecast period. The market encompasses the development, production, and distribution of diagnostic tools specifically designed for LTBI detection. Given the persistent global TB burden, identification of latent infections has become a critical component of international public health strategies. Commonly employed diagnostic methods, such as interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs), play a vital role in screening high-risk populations. As global health organizations intensify efforts to reduce TB incidence, demand for accurate, efficient, and reliable LTBI diagnostic solutions is projected to sustain market growth.

List Of Prominent Players In The Latent Tuberculosis Infection Detection Market:
• QIAGEN
• BIOMÉRIEUX
• Oxford Immunotec
• SD Biosensor, INC.
• Wantai BioPharm
• Lionex GmbH
• Sanofi
• Serum Institute of India Pvt. Ltd
• ARKRAY, Inc.
• Par Pharmaceutical, Inc.
• Abbott,
• F. Hoffmann-La Roche Ltd
• Other Prominent Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The global latent tuberculosis infection (LTBI) diagnostics market is primarily propelled by the growing elderly population, which exhibits heightened vulnerability to LTBI due to age-related immune decline and an increased risk of adverse drug interactions that complicate TB management. Additional factors driving market expansion include rapid urbanization, the rising prevalence of HIV, escalating public health expenditures, and increased investments in tuberculosis prevention programs. Government-led initiatives focused on TB eradication, alongside targeted awareness campaigns, have further elevated demand for LTBI diagnostic solutions, collectively supporting sustained market growth.

Challenges:
Despite promising growth prospects, the LTBI diagnostics market faces several challenges. The emergence of multidrug-resistant tuberculosis (MDR-TB) complicates both diagnosis and treatment, highlighting the critical need for precise and timely detection. Furthermore, stringent regulatory frameworks can slow the introduction of innovative diagnostic technologies, limiting market responsiveness and delaying commercialization. Addressing these challenges requires ongoing investment in advanced detection methods, proactive engagement with regulatory authorities to streamline approval processes, and expanded educational initiatives to promote early diagnosis and preventive intervention.

Regional Trends:
North America is anticipated to maintain robust growth in the LTBI diagnostics market, driven by strong public health policies, sustained governmental efforts toward TB control, and ongoing technological advancements in diagnostic methodologies. The presence of established industry players and substantial R&D investments further reinforce the region's market leadership. Comprehensive screening initiatives targeting high-risk populations also support wider adoption of LTBI testing solutions. Europe similarly holds a significant market position, underpinned by advanced healthcare infrastructure, leading research institutions, and active participation of key industry stakeholders dedicated to improving diagnostic accuracy and optimizing disease management.

Recent Developments:
• In March 2024, QIAGEN formed a cooperation with the International Panel Physicians Association (IPPA) to provide education and assistance to panel physicians throughout the world regarding the most up-to-date tuberculosis screening needs. The primary emphasis will be on the novel IGRA prerequisites and their advantageous implications for patients and healthcare professionals.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2579

Segmentation of latent tuberculosis infection detection market-
By Brand -
• QFT-Plus (QuantiFERON-TB Gold Plus)
• Others
By Test Type -
• Tuberculin Skin Test (TST)
• Interferon Gamma Release Assay (IGRA)
By Application -
• Household Contacts with Pulmonary TB
• PLHIV
• Others
By End-Use -
• Diagnostic Laboratories
• Hospitals/Clinics
• Academic & Research Institutions
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/latent-tuberculosis-infection-detection-market/2579

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.